AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Iowa

HF14

A bill for an act relating to the controlled substance crystalline polymorph psilocybin.(See HF 383.)

Status

Did not pass; died when the session ended

2025 Session

IntroducedJan 14, 2025 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Ann Meyer (Republican)
Type: Scheduling/Trigger Law
Substances: Psilocybin

Official text

Summary (from PoliPsy)

A bill for an act relating to the controlled substance crystalline polymorph psilocybin.(See HF 383.)

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: legis.iowa.gov

Legislative history

February 24, 2025
Withdrawn. H.J. 418.
January 14, 2025
Referred
January 14, 2025
Introduced

Loading bill…